83 related articles for article (PubMed ID: 4591038)
21. Morphological changes of Candida albicans induced by BMY-28864, a highly water-soluble pradimicin derivative.
Numata K; Ueki T; Naito N; Yamada N; Kamasawa N; Oki T; Osumi M
J Electron Microsc (Tokyo); 1993 Jun; 42(3):147-55. PubMed ID: 8376921
[TBL] [Abstract][Full Text] [Related]
22. Direct lethal action of sulconazole and butoconazole.
Beggs WH
Ann Dermatol Venereol; 1991; 118 Suppl 1():5-6. PubMed ID: 2069348
[No Abstract] [Full Text] [Related]
23. Antifungal agents. 7. Dichlorophenylpyrrylimidazolylmethane derivatives: synthesis and antifungal activities.
Massa S; Mai A; Ragno R; Porretta GC; Retico A; Simonetti G; Artico M
Farmaco; 1994 Jan; 49(1):51-5. PubMed ID: 8185750
[TBL] [Abstract][Full Text] [Related]
24. Alpha-omega alkanedithiol, inhibitors of Candida albicans germ tube autoaggregation. A study model of the adherence of pathogenic agents on host cells.
Nasri I; Rahary L; Loppinet V; Bonaly R
Yeast; 1989 Apr; 5 Spec No():S241-4. PubMed ID: 2665358
[No Abstract] [Full Text] [Related]
25. "In vitro" antimycotic activity of fenticonazole (Rec 15/1476).
Costa AL
Mykosen; 1982 Jan; 25(1):47-52. PubMed ID: 7040949
[No Abstract] [Full Text] [Related]
26. [The influence of steroids on the antifungal and antibacterial activities of imidazole derivatives (author's transl)].
Högl F; Raab W
Mykosen; 1980 Aug; 23(8):426-39. PubMed ID: 6999343
[No Abstract] [Full Text] [Related]
27. [Ultrastructural changes in Candida albicans caused by polyene antibiotics (author's transl)].
Scheklakow ND; Delektorski WW; Golodova OA
Mykosen; 1981 Mar; 24(3):140-52. PubMed ID: 7024797
[No Abstract] [Full Text] [Related]
28. [Ultrastructural changes in Candida albicans exposed to polyene antibiotics].
Delektorskiĭ VV; Sheklakov ND; Golodova OA
Vestn Dermatol Venerol; 1980 Nov; (11):14-6. PubMed ID: 7003976
[No Abstract] [Full Text] [Related]
29. Alterations produced by sertaconazole on the morphology and ultrastructure of Candida albicans.
Guarro J; Figueras MJ; Cano J
Mycoses; 1989 Jun; 32(6):283-95. PubMed ID: 2674712
[TBL] [Abstract][Full Text] [Related]
30. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
31. The effect of the morpholine derivate amorolfin (Roche 14-4767/002) on the ultrastructure of Candida albicans.
Müller J; Polak A; Jaeger R
Mykosen; 1987 Nov; 30(11):528-40. PubMed ID: 3328047
[No Abstract] [Full Text] [Related]
32. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
Martínez-Suárez JV; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
[No Abstract] [Full Text] [Related]
33. [Does human plasma decrease the antimicrobial activity of imidazole derivatives? (author's transl)].
Raab W; Högl F
Mykosen; 1981 Aug; 24(8):461-70. PubMed ID: 7024802
[No Abstract] [Full Text] [Related]
34. Antifungal agents. III. Naphthyl and thienyl derivatives of 1H-imidazol-1-yl-4-phenyl-1H-pyrrol-3-ylmethane.
Massa S; Di Santo R; Costi R; Simonetti G; Retico A; Apuzzo G; Artico M
Farmaco; 1993 Jun; 48(6):725-36. PubMed ID: 8373500
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence and sensitivity of Candida albicans in cultures obtained at an oncologic hospital].
Pliego-Castañeda A; Yañez-Viguri A; López-Valle T; Valdés-de la Torre F
Gac Med Mex; 2000; 136(3):193-9. PubMed ID: 10893847
[TBL] [Abstract][Full Text] [Related]
36. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT
J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834
[TBL] [Abstract][Full Text] [Related]
37. Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans.
Braga PC; Sasso MD; Culici M; Alfieri M
Fitoterapia; 2007 Sep; 78(6):396-400. PubMed ID: 17590533
[TBL] [Abstract][Full Text] [Related]
38. Study of the morphofunctional alterations produced by fenticonazole on strains of Candida albicans, using the scanning electron microscope (S.E.M).
Costa AL; Valenti A; Veronese M
Mykosen; 1984 Jan; 27(1):29-35. PubMed ID: 6366540
[No Abstract] [Full Text] [Related]
39. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents.
Harrison JJ; Turner RJ; Ceri H
FEMS Microbiol Lett; 2007 Jul; 272(2):172-81. PubMed ID: 17490429
[TBL] [Abstract][Full Text] [Related]
40. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method].
Quindós G; San Millán R; Burgos A; Lipperheide V; Tellaetxe M; Alonso R; Barturen B; Pontón J
Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
